Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0002007997-25-000004
Filing Date
2025-06-06
Accepted
2025-06-06 17:49:26
Documents
1
Period of Report
2025-06-04

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 6182
  Complete submission text file 0002007997-25-000004.txt   7887
Mailing Address C/O ONCORE BIOPHARMA, INC. 3805 OLD EASTON ROAD DOYLESTOWN PA 18902
Business Address
Ramaswamy Vivek (Reporting) CIK: 0001635075 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40782 | Film No.: 251032258

Mailing Address 7TH FLOOR, 50 BROADWAY LONDON UNITED KINGDOM United Kingdom SW1H 0DB
Business Address 7TH FLOOR, 50 BROADWAY LONDON UNITED KINGDOM United Kingdom SW1H 0DB 441-295-5950
Roivant Sciences Ltd. (Issuer) CIK: 0001635088 (see all company filings)

EIN.: 981173944 | State of Incorp.: D0 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)